Paramedic PapersHome Sepsis & infection EDs: opportunistic immunisation, not vaccine clinics
Sepsis & infection
EDs: opportunistic immunisation, not vaccine clinics
Does the Emergency Department Have a Role in Immunisation? Yes—But Not as a Routine Vaccine Clinic
Emergency Medicine Australasia · Added 4 August 2026
Editorial arguing EDs should provide opportunistic, proportionate immunisation for vulnerable patients rather than functioning as routine vaccine clinics
- Study type
- Guideline / statement
- Design
- Editorial
- Participants
- Not reported
- Bottom line
- Context only
Why it matters in Australia (Medium relevance). transferability — Relevant to understanding the role EDs (and by extension, paramedics) play in immunisation, though less directly actionable for pre-hospital care
Learning goal
Build my judgement on when opportunistic immunisation in the emergency setting benefits vulnerable patients.
More
- Topic: Sepsis & infection
- Daily scan: 4 August 2026
Related papers on Sepsis & infection
-
Prehospital antibiotics earlier in sepsis
Thai observational cohort of 364 adults with suspected sepsis testing prehospital antibiotics — prehospital administration was associated with lower adjusted 28-day mortality (ARR 8.9%, 95% CI 0.8–17.1; aOR 0.51) and antibiotics ~125 minutes sooner, but scene times ran 8.5 minutes longer.
-
Eight sepsis subgroups found, SENECA not replicated
Retrospective consensus clustering of 953 ED sepsis admissions at Oslo University Hospital could not replicate the four SENECA phenotypes, instead finding eight stable subgroups with more granular characteristics — and only 49% of patients meeting SENECA inclusion criteria fulfilled Sepsis-3, underlining sepsis heterogeneity and cohort-definition problems.
-
Vaccine-preventable diseases re-emerging in EDs
Editorial on the re-emergence of vaccine-preventable diseases post-COVID — declining vaccination rates are causing outbreaks of diphtheria, measles, and other VPDs in Australasia
-
Diphtheria re-emergence and ED impact
ABSTRACT Diphtheria has re‐emerged in Australia in 2026, prompting significant public health concern and placing additional demands on healthcare services.